Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Aspira Women's Health Inc. AWH
$3.60
-$0.24 (-6.61%)
На 18:02, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
36929958.00000000
-
week52high
1.10
-
week52low
0.27
-
Revenue
8184000
-
P/E TTM
-2
-
Beta
2.93252500
-
EPS
-0.20000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Truist Securities | Buy | 29 мар 2021 г. | |
| Cantor Fitzgerald | Overweight | 29 янв 2021 г. | |
| William Blair | Outperform | 30 окт 2020 г. | |
| Cantor Fitzgerald | Neutral | Overweight | 20 янв 2023 г. |
| JP Morgan | Neutral | Overweight | 06 янв 2017 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sandford Nicole | A | 5000 | 5000 | 01 дек 2022 г. |
| Sandford Nicole | A | 5000 | 5000 | 01 ноя 2022 г. |
| Sandford Nicole | A | 5000 | 5000 | 03 окт 2022 г. |
| Sandford Nicole | A | 5000 | 5000 | 03 окт 2022 г. |
| Sandford Nicole | A | 5000 | 5000 | 01 сент 2022 г. |
| Merchant Minh Hoang | A | 26667 | 26667 | 25 авг 2022 г. |
| Merchant Minh Hoang | A | 14700 | 0 | 25 авг 2022 г. |
| Merchant Minh Hoang | A | 46667 | 26667 | 25 авг 2022 г. |
| Fralick Celeste Rachelle | A | 6667 | 6667 | 25 авг 2022 г. |
| Fralick Celeste Rachelle | A | 102945 | 6667 | 25 авг 2022 г. |
Новостная лента
Aspira Women's Health Inc. (AWH) Q3 2022 Earnings Call Transcript
Seeking Alpha
10 ноя 2022 г. в 14:33
Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Ryan Phan - Chief Scientific Officer and Chief Operating Officer Robert Beechey - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Griffin Soriano - William Blair & Company Operator Good morning, ladies and gentlemen, and welcome to Aspira Women's Health Incorporated Third Quarter 2022 Conference Call. My name is David, and I will be your coordinator for the call today.
Down 38.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Aspira (AWH)
Zacks Investment Research
24 авг 2022 г. в 11:18
The heavy selling pressure might have exhausted for Aspira (AWH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Aspira Women's Health, Inc. (AWH) CEO Nicole Sandford on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
10 авг 2022 г. в 14:01
Aspira Women's Health, Inc. (NASDAQ:AWH ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Robert Beechey - Chief Financial Officer Ryan Phan - Chief Scientific Officer and Chief Operating Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Operator Good morning, ladies and gentlemen and welcome to Aspira Women's Health Inc. Second Quarter 2022 Conference Call. My name is Vikram and I will be your coordinator for the call today.
Aspira Women's Health, Inc. (AWH) CEO Nicole Sandford on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
11 мая 2022 г. в 11:57
Aspira Women's Health, Inc. (NASDAQ:AWH ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Nicole Sandford - President, Chief Executive Officer and Director Robert Beechey - Chief Financial Officer Michael Newton - Head, Commercial Conference Call Participants Brian Weinstein - William Blair & Company Ross Osborn - Cantor Fitzgerald & Co. Nicole Sandford Thank you, operator, and thank you to all of you for joining us today. I'll start with a business update before I hand the call over to Bob to review our Q1 financial performance.
Aspira (AWH) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
11 мая 2022 г. в 09:47
Aspira (AWH) delivered earnings and revenue surprises of 0% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?